BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6232944)

  • 1. Steroid receptors and response of ovarian cancer to hormones in vitro.
    Grönroos M; Kangas L; Mäenpää J; Vanharanta R; Nieminen AL; Johansson R
    Br J Obstet Gynaecol; 1984 May; 91(5):472-8. PubMed ID: 6232944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid receptors and response of ovarian cancer to cytostatic drugs in vitro.
    Grönroos M; Kangas L; Mäenpää J; Vanharanta R; Paul R
    Br J Obstet Gynaecol; 1984 May; 91(5):479-82. PubMed ID: 6232945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
    van den Berg HW; Martin J; Lynch M
    Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid receptors and response of endometrial cancer to hormones in vitro.
    Grönroos M; Mäenpää J; Kangas L; Erkkola R; Paul R; Grenman S
    Ann Chir Gynaecol Suppl; 1987; 202():76-9. PubMed ID: 2959189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen and progesterone receptor titers in primary epithelial ovarian carcinomas.
    Jones LA; Edwards CL; Freedman RS; Tan MT; Gallager HS
    Int J Cancer; 1983 Nov; 32(5):567-71. PubMed ID: 6315602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid receptors and response to hormonal and cytotoxic agents in vitro in two cases of androblastoma.
    Taina E; Mäenpää J; Erkkola R; Grönroos M
    Ann Chir Gynaecol Suppl; 1987; 202():80-2. PubMed ID: 2959190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hormone dependence of malignant ovarian tumors--an in vitro model].
    Schieder K; Bieglmayer C; Kölbl H
    Geburtshilfe Frauenheilkd; 1989 May; 49(5):437-41. PubMed ID: 2544477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid hormone receptors and response to high-dose medroxyprogesterone acetate in advanced breast cancer.
    Nomura Y; Tashiro H; Hisamatsu K; Shinozuka K
    Anticancer Res; 1988; 8(4):647-51. PubMed ID: 2972248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inability of medroxyprogesterone acetate to down regulate estrogen receptor level in human breast cancer.
    Noguchi S; Yamamoto H; Inaji H; Imaoka S; Koyama H
    Cancer; 1990 Mar; 65(6):1375-9. PubMed ID: 2137722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of tamoxifen-medroxyprogesterone sequential therapy on estrogen and progesterone receptor contents of breast cancer.
    Noguchi S; Yamamoto H; Inaji H; Imaoka S; Koyama H
    Jpn J Cancer Res; 1989 Mar; 80(3):244-8. PubMed ID: 2524460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytoplasmatic receptors of steroid hormones in malignant epithelial ovarian tumors].
    Makhova EE; Gershteĭn ES; Smirnova KD; Murav'eva NI; Kuz'mina ZV
    Vopr Onkol; 1984; 30(12):36-40. PubMed ID: 6516272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estradiol and progesterone receptors in normal ovary and ovarian tumors.
    Lantta M
    Acta Obstet Gynecol Scand; 1984; 63(6):497-503. PubMed ID: 6507051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of medroxyprogesterone acetate antineoplastic activity by histidine in rat mammary tumours.
    Di Carlo F; Conti G; Giubertoni M; Muccioli G; Racca S
    Cancer Chemother Pharmacol; 1991; 27(4):271-7. PubMed ID: 1825621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal activity of epithelial ovarian tumours in post-menopausal women.
    Heinonen PK; Mörsky P; Aine R; Koivula T; Pystynen P
    Maturitas; 1988 Mar; 9(4):325-38. PubMed ID: 3380017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of estrogen and progesterone cytosol receptor concentration in benign and malignant ovarian tumors and a review of malignant ovarian tumors treated with medroxy-progesterone acetate.
    Bergqvist A; Kullander S; Thorell J
    Acta Obstet Gynecol Scand Suppl; 1981; 101():75-81. PubMed ID: 6946676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of steroid receptors and aromatase activity in the prognosis of ovarian cancer: high tumor progesterone receptor levels correlate with longer survival.
    Slotman BJ; Kühnel R; Rao BR; Dijkhuizen GH; de Graaff J; Stolk JG
    Gynecol Oncol; 1989 Apr; 33(1):76-81. PubMed ID: 2703171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Steroid receptors in epithelial ovarian tumors].
    Klarić P; Kanajet D; Cvrtila D
    Jugosl Ginekol Perinatol; 1987; 27(3-4):77-9. PubMed ID: 3431144
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro responsiveness of ovarian epithelial carcinomas to endocrine therapy.
    Runge HM; Teufel G; Neulen J; Geyer H; Pfleiderer A
    Cancer Chemother Pharmacol; 1986; 16(1):58-63. PubMed ID: 2933176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effect of tamoxifen alone versus tamoxifen in combination wtih gestagen and oestrogen in advanced breast cancer.
    Mouridsen HT; Palshof T; Rose C
    Recent Results Cancer Res; 1980; 71():169-77. PubMed ID: 6988913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of high-dose medroxyprogesterone acetate in advanced breast cancer, with special reference to prior endocrine therapy and hormone receptors].
    Nomura Y; Tashiro H; Hisamatsu K; Toi M
    Gan To Kagaku Ryoho; 1988 Mar; 15(3):513-8. PubMed ID: 2964811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.